Integrative multi-omics identifies regulatory and exhausted T cell types and novel immunotherapy targets in CLL lymph nodes
Martina Seiffert(German Cancer Research Center), Elı́as Campo(Hospital Clínic de Barcelona), Peter‐Martin Bruch(European Molecular Biology Organization), Jérôme Paggetti(Luxembourg Institute of Health), Antonio Cosma(Luxembourg Institute of Health), Laura Llaó Cid(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Margot Chazotte(Heidelberg University), Etienne Moussay(Luxembourg Institute of Health), Susanne Gonder(Luxembourg Institute of Health), Marc Zapatka(German Cancer Research Center), Elena Hartmann(University of Würzburg), Sascha Dietrich(European Molecular Biology Organization), Jan‐Philipp Mallm(German Cancer Research Center), Daniel Campton(Seattle University), John Wong, Giulia Pagano(Luxembourg Institute of Health), Denis Schapiro(Heidelberg University), Tobias Roider(European Molecular Biology Organization), Dolors Colomer(Hospital Clínic de Barcelona), Marina Wierz(Luxembourg Institute of Health), Murat Iskar(German Cancer Research Center), Iria Fernandez Botana(Luxembourg Institute of Health), Christoph Schifflers(German Cancer Research Center), Felix Czernilofsky(Heidelberg University), Kresimir Bestak(Heidelberg University), Alessia Floerchinger(German Cancer Research Center), Peter Lichter(German Cancer Research Center), Yashna Paul(German Cancer Research Center)
Cited by 0
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
|Nature Methods|2014|2k